Dehydroepiandrosterone sulphate in critical illness: effect of dopamine
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: OBJECTIVE As part of a study on the effect of dopamine therapy on pituitary dependent hormone secretion in critical illness, we documented the impact of this inotropic and vasoactive catecholamine on the serum concentrations of dehydroepiandrosterone sulphate (DHEAS). Concomitantly, serum levels of PRL and cortisol were determined. PATIENTS AND DESIGN In a prospective, randomized, controlled, open‐labelled clinical study, 20 critically ill, adult polytrauma patients receiving dopamine treatment (5 μg/kg/ml i.v. for a median 109 hours (range 21–296 hours), were studied to evaluate the effect of dopamine withdrawal on serum concentrations of DHEAS, PRL and cortisol. The median age of the studied patients was 37 years (range 18–83 years) MEASUREMENTS Serum DHEAS and cortisol concentrations were measured by RIA and PRL by IRMA. The assessed serum samples were obtained at 0300h on each of two consecutive study nights. RESULTS Withdrawal of dopamine infusion was found to elicit a median 25% Increase of serum DHEAS concentrations within 24 hours whereas no significant change in DHEAS levels was observed when dopamine infusion was continued throughout both study nights (P= 0.01 continued vs interrupted dopamine). Prolactin levels were undetectable as long as dopamine was infused, and increased to a median of 317 IU/I after 24 hours of dopamine withdrawal (P = 0.0007). Elevated serum cortisol levels remained comparable with continued and interrupted dopamine infusion. CONCLUSIONS Dopamine infusion appears to suppress serum DHEAS concentrations in critically ill patients without affecting their elevated serum cortisol levels, suggesting a differential regulation of DHEAS and cortisol metabolism in critical illness. The lowering effect of dopamine on DHEAS levels could be linked to the concomitant suppression of circulating PRL. The simultaneous suppression of circulating PRL and DHEAS by dopamine infusion may be an iatrogenic factor maintaining or aggravating the anergic state of prolonged severe illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264 · cited 1×
“Indeed, restoration of DHEA content has been shown to correct immunological defects in conditions of low serum DHEAS concentrations (Araneo et al., 1193 a,b; Daynes et al., 1993; Casson et al., 1993).”
BackgroundDehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.
Suzuki, T., Suzuki, N., Daynes, R. A., & Engleman, E. G. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80024-8 · Cited by 277
Prolactin modulation of dehydroepiandrosterone sulfate secretion
Lobo, R. A., Kletzky, O. A., Kaptein, E. M., & Goebelsmann, U. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90079-4 · Cited by 120
Effect of prolactin on plasma DHEA(S) levels
Vermeulen, A., Suy, E., & Rubens, R. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1222 · Cited by 97 · cited 1×
“In hyperprolactinaemic women and healthy men, increases in serum levels of PRL and DHEAS are linked, and a decrease in serum PRL is followed by a fall in serum DHEAS (Vermeulen et al., 1977; Lob0 et al., 1980; Schiebinger et al., 1986).”
BackgroundSCHIEBINGER, R. J., CHROUSOS, G. P., CULTER, G. B., & LORIAUX, D. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-202 · Cited by 73
Cited by
Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms1
Van den Berghe, G., de Zegher, F., & Bouillon, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4763 · Cited by 342
Self-citationArafah, B. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0674 · Cited by 332
Novel insights into the neuroendocrinology of critical illness
Van den Berghe, G. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430001 · Cited by 257
Vasopressor and inotropic support in septic shock: An evidence-based review
Beale, R. J., Hollenberg, S. M., Vincent, J.-L., & Parrillo, J. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142909.86238.b1 · Cited by 260
Anterior pituitary function during critical illness and dopamine treatment
Van den Berghe, G., & de Zegher, F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00024 · Cited by 256
Self-citation
Metadata
- Authors
- Van den Berghe, G., de Zegher, F., Wouters, P., Schetz, M., Verwaest, C., Ferdinande, P., & Lauwers, P.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1995-10
- Volume
- 43
- Issue
- 4
- Pages
- 457-463
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2093442315
- Cited by
- 61
- References
- 5
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. https://app.cochat.ai/papers/10.1111/j.1365-2265.1995.tb02618.x
- The paper
- Van den Berghe, G., de Zegher, F., Wouters, P., Schetz, M., Verwaest, C., Ferdinande, P., & Lauwers, P. (1995). Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1995.tb02618.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.